Tagged with J

UAE Vishnu Kalra, Janssen’s managing director for the GCC region, reflects on his 18-year career with Johnson & Johnson, including his perspective on the success factors behind the company’s strong growth in the region. Moreover, he highlights Janssen’s diversified portfolio across different therapeutic areas, with neuroscience, oncology, haematology, pulmonary arterial hypertension…

Asia-Pacific Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous progress the pharmaceutical industry has made in the Asia-Pacific region over the last ten years and highlights how the industry needs to adapt to meet emergent challenges.   By…

China Michael Zhang, chairman of Peijia Medical, shares Peijia Medical’s mission to become a two-platform medical device company as well as the partner of choice for physicians in China and globally. Peijia Medical’s recent achievements include a Series C round, of over USD 100 million, and the successful completion of clinical…

UAE Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets throughout the Gulf, mental health, and corporate social responsibility (CSR) initiatives in the region.   The Gulf markets are very open to innovation and eager to bring the most…

India The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover and 28 percent of its pharmaceutical exports.  Given the tremendous importance of the Indian industry globally, this state therefore emerges as a pharmaceutical hub of global importance.   For…

Thailand Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas market back in 1973. Yuasa goes on to highlight how the affiliate is overcoming the obstacles present in the Thai pharma market and how it is contributing to the country’s growing medical food…

China Dr Irwin Wang, CEO of Reistone Biopharma, shares her motivations behind the establishment of the company, their extremely productive collaboration with Jiangsu Hengrui (China’s largest pharma company by market capitalization), and their exciting international clinical development strategy for their three assets.   I realized that if I wanted to establish…

USA BioNJ’s president and CEO Debbie Hart reflects on the association’s mission of creating a robust and engaging life sciences ecosystem in New Jersey. Hart also outlines how BioNJ is hoping to continue to grow the region’s reputation as a hub that stands out for its level of expertise, favourable geographic…

Sweden Simon Björklund, CEO of Bioglan, a Swedish CDMO owned by Reig Jofre, explains the company’s twofold business model of developing and manufacturing products for local and international clients. He highlights the advantages of manufacturing and operating in Sweden, while emphasizing his future vision of developing and out-licensing Bioglan’s own products.…

UAE The UAE is putting a greater emphasis on healthcare than ever before as part of its ‘Vision 2021’ model. With the aim of being “flexible in adopting new economic models and capitalizing on global economic partnerships,” the Emirates are seeing greater numbers of investments and partnerships in healthcare, many of…

Sweden Changing demographics and revolutionary technological advancements are altering the structure of the medtech industry paving the way for Arjo, a global Swedish supplier of medical devices and solutions, to rise up to the challenge. CEO Joacim Lindoff discusses the journey after Arjo’s split from Getinge in 2017, the company’s revived…

China Given the undeniably challenging and dynamic China market, most industry stakeholders would agree that the paramount factor behind the success of multinationals’ China affiliates is talent – not only at the top leadership level but throughout the organization. A few country managers share their talent strategies, as well as the…